Rafeh Naqash, MD
@thenasheffect
Asst Prof. @StephensonCC Phase 1 trials #IMmunoOnc and PrecisionMed, #PhyscianNOTProvider @JCOPO_ASCO social media editor #FromKashmir ● #SpaceAndMedicine 👨🚀
ID:1040953506520293377
https://www.google.com/amp/s/www.researchgate.net/profile/Abdul_Rafeh_Naqash2/amp 15-09-2018 13:20:30
2,8K Tweet
2,1K Takipçi
1,8K Takip Edilen
Growth of the #TECAG and Trainee lounge is a testament to what a phenomenal impact ASCO TECAG has had. THIS lounge is where ALL the magic happens: collaborations, networking, camaraderie, science, sessions! IMG Oncologists Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Jacob J. Adashek, DO Fernando Diaz, MD
Amazing cover story about Karen Knudsen, MBA PhD of American Cancer Society from The Cancer Letter today! Great turnaround of a critically important organization! cancerletter.com
'Caring for patients is both humbling and rewarding. You meet patients in their most vulnerable state, and they often trust you with their most valuable assets—their body and their loved ones.' Learn about #cardiology clinical fellow Sarah Abou Alaiwi, MD, medicine.yale.edu/internal-medic…
‼️Excited to share work led by #ACTan lab Huntsman Cancer Institute in developing irAE explorer an interactive tool for irAEs now out in #TheOncologist irae.tanlab.org Siwen Hu-Lieskovan
academic.oup.com/oncolo/article…
Giants of Cancer Care 2024
Congrats Solange Peters for your outstanding dedication, leadership, and commitment to advancing lung cancer research!
onclive.com/view/giants-of… via @onclive
We need MORE advocacy and implementation of similar approaches for other states ! Karen Knudsen, MBA PhD American Cancer Society
Thrilled to have the Macrophage 👸 Jennifer Guerriero, PhD herself at OU Health Stephenson Cancer Center for the Div Of Onc Sciences Grand Rounds,and reflecting on how we met at 2018 Society for Immunotherapy of Cancer #Sparkathon and now Jenn being on board of directors for #SITC Society for Immunotherapy of CancerECS
Looking forward to CoChairing the Developmental Therapeutics -Immunotherapy Orals ASCO with the ⭐️Tian Zhang, MD, MHS.We have a superb line up of speakers and cutting edge IO trails @asco #ASCO24 # Dan Olson Ulka Vaishampayan Anthony P Conley Elena Garralda Sandra P D'Angelo, MD and others
Super important work led by Coral Olazagasti, MD , looking forward to the session IMG Oncologists Nazli Dizman Fernando Diaz, MD ASCO TECAG
‼️🚨ASCO #ASCO24 abstracts LIVE now! Join us June 2 for our teams ORAL🙌👏 abstract on work led by Amin Nassar, MD that will presented by RitujithJayakrishnan on consolidation ALK in locally advanced NSCLC. Elio Adib JessicaJLinMD Jair Bar Ana I. Velázquez Mañana, MD MSc (she/her/ella) and others !
Getting two plenaries from one track (early stage NSCLC /meso/ sclc) and 3 plenaries in Lung Ca !!! Super thrilled to have been part of the track that might have just created history !!! Patrick Forde Shankar Siva Melina Marmarelis Lecia Sequist, MD, MPH Lynn M. Schuchter, MD, FASCO Angie DeMichele, MD, MSCE, FASCO
Meet the Author: Amin H. Nassar (Amin Nassar, MD), a medical oncology fellow from Yale Cancer Center, is co-1st author of “Clinical Outcomes and Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Paraneoplastic Syndromes,” recently published in #JITC ! 1/6
2024 #ASCOAdvocacySummit brought 170+ ASCO members representing 48 states—incl. Alaska & Hawaii—plus DC and Puerto Rico. Such an inspiring & energizing week of bold action in our Nation’s capital on behalf of our patients.
Advocate year-round at: asco.org/ACTnetwork